TUMOR NECROSIS FACTOR INHIBITORS

You have access
Relation of NSAIDs, DMARDs, and TNF Inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee Arthroplasty
Rachael Stovall, Christine Peloquin, David Felson, Tuhina Neogi and Maureen Dubreuil

The Journal of Rheumatology July 1 2021, 48 (7) 1007-1013; DOI: https://doi.org/10.3899/jrheum.200453
You have access
Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Michael D. George, Joshua F. Baker and Alexis Ogdie

The Journal of Rheumatology June 1 2020, 47 (6) 826-834; DOI: https://doi.org/10.3899/jrheum.190299
You have access
Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register
Elsa Vieira-Sousa, Mónica Eusébio, Pedro Ávila-Ribeiro, Nikita Khmelinskii, Rita Cruz-Machado, Teresa Martins Rocha, Miguel Bernardes, Daniela Santos-Faria, Joana Leite Silva, Helena Santos, Cláudia Miguel, Pedro Carvalho, Tiago Costa, Ana Catarina Duarte, Tiago Meirinhos, Patrícia Nero, João Eurico Fonseca and Maria José Santos

The Journal of Rheumatology May 1 2020, 47 (5) 690-700; DOI: https://doi.org/10.3899/jrheum.181272
You have access
Toward Defining Primary and Secondary Nonresponse in Rheumatoid Arthritis Patients Treated with Anti-TNF: Results from the BioTRAC and OBRI Registries
Edward C. Keystone, Emmanouil Rampakakis, Mohammad Movahedi, Angela Cesta, Melissa Stutz, John S. Sampalis, Francois Nantel, Karina Maslova and Claire Bombardier

The Journal of Rheumatology April 1 2020, 47 (4) 510-517; DOI: https://doi.org/10.3899/jrheum.190102
Open Access
Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial
Arthur Kavanaugh, M. Elaine Husni, Diane D. Harrison, Lilianne Kim, Kim Hung Lo, Lenore Noonan and Elizabeth C. Hsia

The Journal of Rheumatology June 1 2019, 46 (6) 595-602; DOI: https://doi.org/10.3899/jrheum.180681
You have access
Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy
Geneviève Genest, Karen A. Spitzer and Carl A. Laskin

The Journal of Rheumatology August 1 2018, 45 (8) 1109-1115; DOI: https://doi.org/10.3899/jrheum.171152
Open Access
Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence
Irini D. Flouri, Theodora E. Markatseli, Kyriaki A. Boki, Ioannis Papadopoulos, Fotini N. Skopouli, Paraskevi V. Voulgari, Loukas Settas, Dimitrios Zisopoulos, Alexios Iliopoulos, Pierre Geborek, Alexandros A. Drosos, Dimitrios T. Boumpas and Prodromos Sidiropoulos

The Journal of Rheumatology June 1 2018, 45 (6) 785-794; DOI: https://doi.org/10.3899/jrheum.170477
You have access
Application of Recommendations Regarding the Use of Subcutaneous Tumor Necrosis Factor Inhibitors in Spondyloarthritis by Rheumatologists in Daily Practice
Céline Pereira-Gillion, Mathilde Marot, Isabelle Griffoul-Espitalier, Lucia Andras, Philippe Goupille and Carine Salliot

The Journal of Rheumatology April 1 2018, 45 (4) 491-497; DOI: https://doi.org/10.3899/jrheum.170587
You have access
Measuring Disease Exacerbation and Flares in Rheumatoid Arthritis: Comparison of Commonly Used Disease Activity Indices and Individual Measures
Martijn A.H. Oude Voshaar, Marjan Ghiti Moghadam, Harald E. Vonkeman, Peter M. ten Klooster, Dirkjan van Schaardenburg, Janneke Tekstra, Henk Visser, Mart A.F.J. van de Laar and Tim L. Jansen

The Journal of Rheumatology August 1 2017, 44 (8) 1118-1124; DOI: https://doi.org/10.3899/jrheum.160915
You have access
Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years
Denis Poddubnyy, Aleksandra Fedorova, Joachim Listing, Hildrun Haibel, Xenofon Baraliakos, Jürgen Braun and Joachim Sieper

The Journal of Rheumatology December 1 2016, 43 (12) 2142-2148; DOI: https://doi.org/10.3899/jrheum.160594

Main menu

User menu

Search

TUMOR NECROSIS FACTOR INHIBITORS

Pages

Content

Resources

Subscribers

More